Royal Bank of Canada’s bluebird bio BLUE Stock Holding History

Royal Bank of Canada’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,544	Closed	-$1.28M	–	6351
2015 Q4	$1.28M	Buy	+1,544	New	+$1.54M	﹤0.01%	2911

Other funds holding BLUE

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Royal Bank of Canada's BLUE Position: Q2 2025 in Review

Royal Bank of Canada sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 1,145 shares — an estimated $5K sold.

Royal Bank of Canada first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $160M in Q2 2020. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

Royal Bank of Canada reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
Royal Bank of Canada sold 1,145 bluebird bio shares in Q2 2025, an estimated $5K.
Royal Bank of Canada first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
Royal Bank of Canada's bluebird bio position peaked at $160M in Q2 2020.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Royal Bank of Canada's 13F filing for Q2 2025, filed 14 Aug 2025.